Related Experiment Videos
Transfusion medicine for the pediatrician
1Department of Clinical Laboratory Medicine, University of California, San Francisco, Moffitt-Long Hospital, 505 Parnassus Avenue, San Francisco, CA 94143-0100, USA. kquirolo@mail.cho.org
Pediatric Clinics of North America
|February 13, 2003
Summary
Future blood transfusion practices will enhance safety and availability through advanced pathogen testing and improved preservation methods. Continued vigilance remains crucial for managing inherent risks associated with blood products.
Area of Science:
- Hematology
- Transfusion Medicine
- Immunology
Background:
- Blood transfusion is a critical medical therapy with inherent risks.
- Current methodologies are evolving to improve transfusion safety and product availability.
Purpose of the Study:
- To review emerging methodologies and research in transfusion medicine.
- To project future advancements in blood product safety and accessibility.
Main Methods:
- Review of current and emerging research in transfusion medicine.
- Analysis of advancements in pathogen detection, preservation, and antigen modification.
Main Results:
- Nucleic acid testing (NAT) will become standard for all blood products.
- Pathogen detection methods like PCR will advance.
- Understanding of transfusion-related events (TRALI, immunomodulation) will improve.
- New preservation techniques and contamination detection will extend product shelf-life.
- Red blood cell antigen attenuation will increase product compatibility.
Conclusions:
- Future clinical practice will incorporate advanced transfusion technologies.
- Enhanced safety and universal availability of blood products are anticipated.
- Clinical vigilance remains essential for managing transfusion risks.